Polyneuropathy Treatment in DNTRIPLED Medical Services Therapeutic Apheresis Center

DNTRIPLED Medical Services – Modern Apheresis is a private single-specialty medical center located in Warsaw, Poland, specializing in advanced therapeutic apheresis, including double-filtration plasmapheresis (DFPP), LDL apheresis, and hemoperfusion. All procedures are performed under direct physician supervision in accordance with recognized American and German clinical guidelines, using modern apheresis systems from Medica S.p.A. (Italy) and sterile single-use kits. The clinic serves only adult patients and is most frequently visited by patients from Europe and the Commonwealth, as well as the USA, Canada, and Australia.

The clinic focuses on extracorporeal blood purification therapies designed for patients with complex metabolic, inflammatory, autoimmune, and cardiovascular conditions, as well as those seeking support in longevity, detoxification, and improvement of physical and cognitive performance. Treatment is based on individualized medical assessment and performed in a controlled clinical environment using advanced filtration and adsorption technologies.

Therapeutic apheresis procedures—including double-filtration plasmapheresis (DFPP), hemoperfusion, and LDL apheresis—are extracorporeal blood purification methods in which blood is processed outside the body to selectively remove targeted pathogenic substances before being returned to the circulation. The goal is to reduce the concentration of specific circulating factors that may contribute to disease development or progression.

Double-filtration plasmapheresis (DFPP) is a two-stage blood purification technique in which plasma is separated from blood cells and further filtered through specialized membranes. This allows selective reduction of immune complexes, autoantibodies, immunoglobulins, lipoproteins, inflammatory mediators, heavy metals, and selected toxins. Depending on the condition, DFPP may support immune modulation, reduction of systemic inflammation, and improvement of metabolic balance and cellular function.

LDL apheresis is a selective therapeutic procedure aimed at reducing LDL cholesterol and lipoprotein(a) levels through plasma separation and adsorption-based filtration. It may help lower atherogenic lipoproteins, reduce cardiovascular risk, slow progression of atherosclerosis, stabilize plaques, and improve long-term outcomes in patients with treatment-resistant dyslipidemia.

Hemoperfusion is a blood purification technique in which whole blood passes through adsorption cartridges that remove specific toxins and biologically active substances. Depending on clinical indications, this may include inflammatory mediators, cytokines, bilirubin, metabolic toxins, drug overdoses, poisons, β2-microglobulin, excess parathyroid hormone, leptin, protein-bound toxins, triglycerides, LDL cholesterol, and myoglobin. Potential effects include reduction of toxic load, decreased systemic inflammation, and support of metabolic stabilization depending on the underlying condition.

Clinical outcomes depend on the underlying disease and individual patient condition and cannot be guaranteed.